Concepedia

Hanzhe Zhang

HZ

Statistics

Publications

3

Citations

390

H-Index

3

Active since

2018

Affiliations

Johns Hopkins Medicine(Current)

Johns Hopkins University

Hanzhe Zhang is an author at Johns Hopkins Medicine specializing in drug approval, yes-associated protein signaling, and segmental bone defect repair.

ORCID

Publications per year

2018–2024

3

Publications

3

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016

Thomas J. Moore, Hanzhe Zhang, Gerard F. Anderson et al. · JAMA Internal Medicine · 2018 · 355 citations · Full text

, , +17

Tensile Stress‐Activated and Exosome‐Transferred YAP/TAZ‐Notch Circuit Specifies Type H Endothelial Cell for Segmental Bone Regeneration

Feng Wang, Shanyu Li, Lingchi Kong et al. · Advanced Science · 2024 · 24 citations · Full text

, , +17

Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis

Hanzhe Zhang, Jiajun Wen, G. Caleb Alexander et al. · RMD Open · 2021 · 11 citations · Full text

, , +17

1–3 of 3